Design and Size of Bioequivalence Studies for Inhaled Drugs

Title
Design and Size of Bioequivalence Studies for Inhaled Drugs

Abstract
Bioequivalence for different formulations of inhaled drugs poses special problems that require clinical studies in patients. I argue that these should contain multiple doses per formulation and derive a simple formula for the calculation of sample size for such studies.